Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial

Claes Held, Pierluigi Tricoci, Zhen Huang, F Van De Werf, Harvey White, Paul Armstrong, Giuseppe Ambrosio, Philip Aylward, David Moliterno, Lars Wallentin, Edmond Chen, Aycan Erkan, Lixin Jiang, John Strony, Robert Harrington, Kenneth Mahaffey

    Research output: Contribution to journalArticlepeer-review

    11 Citations (Scopus)

    Fingerprint Dive into the research topics of 'Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial'. Together they form a unique fingerprint.

    Medicine & Life Sciences